Role of Platelets in Restenosis After Percutaneous Coronary Revascularization

This publication has 80 references indexed in Scilit:

• Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor.
  Journal of Clinical Investigation, 1996
• 914-72 Platelet––Stimulated Proliferation of Coronary Smooth Muscle Cells
  Journal of the American College of Cardiology, 1995
• Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months
  The Lancet, 1994
• Pharmacologic prevention of restenosis after coronary angioplasty
  Coronary Artery Disease, 1993
• Inhibition of Neointimal Smooth Muscle Accumulation After Angioplasty by an Antibody to PDGF
  Science, 1991
• Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor.
  Proceedings of the National Academy of Sciences, 1991
• Role of basic fibroblast growth factor in vascular lesion formation.
  Circulation Research, 1991
• Percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris: Analysis of early and late results
  American Heart Journal, 1983
• Percutaneous transluminal coronary angioplasty in patients with variant angina.
  Circulation, 1982
• Nonoperative Dilatation of Coronary-Artery Stenosis
  New England Journal of Medicine, 1979